Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.54
Delayed Data
As of Jun 23
 +0.08 / +3.25%
Today’s Change
1.93
Today|||52-Week Range
3.77
+19.81%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close2.46
Today’s open2.48
Day’s range2.43 - 2.60
Volume3,675,588
Average volume (3 months)1,849,881
Market cap$408.9M
Dividend yield7.88%
Data as of 4:14pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)-47.01%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio28.2
Price/Sales1.45
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...-0.25-1.69%
CYADCelyad SA-1.80-3.85%
BLCMBellicum Pharmaceuti...-0.59-4.22%
NSTGNanoString Technolog...+0.53+3.28%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts